Skip to main content
Toggle navigation
Login
Search
Home
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Favorite
Like
Tweet
Print
Annie Lumen, Ph.D.
Principal Scientist
Amgen Inc
Poster(s):
010: Development of a Mechanistic-Physiologically Based Pharmacokinetic Platform Model to Guide Adult & Pediatric Dosing for Bispecific T Cell Engagers through Intravenous & Subcutaneous Administration
Sunday, September 10, 2023
5:00 PM - 7:00 PM
PT
041: Predicting Clinical PK/PD & Impacts of Organ Impairment to Support Clinical Development of siRNA-based Therapeutics Using a Mechanistic Physiologically Based Pharmacokinetic & Pharmacodynamic (PBPK-PD) Platform Model
Sunday, September 10, 2023
5:00 PM - 7:00 PM
PT
108: Development of a Mechanistic-Physiologically Based Pharmacokinetic Platform Model to Guide Adult & Pediatric Dosing for Bispecific T Cell Engagers through Intravenous & Subcutaneous Administration
Monday, September 11, 2023
5:00 PM - 7:00 PM
PT
